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in the Mouse Intestine and in M9 Minimal Medium
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Escherichia coli MG1655 uses several sugars for growth in the mouse intestine. To determine the roles of
L-fucose and D-ribose, an E. coli MG1655 fucAO mutant and an E. coli MG1655 rbsK mutant were fed
separately to mice along with wild-type E. coli MG1655. The E. coli MG1655 fucAO mutant colonized the
intestine at a level 2 orders of magnitude lower than that of the wild type, but the E. coliMG1655 rbsKmutant
and the wild type colonized at nearly identical levels. Surprisingly, an E. coli MG1655 fucAO rbsK mutant
was eliminated from the intestine by either wild-type E. coliMG1655 or E. coliMG1655 fucAO, suggesting that
the fucAO mutant switches to ribose in vivo. Indeed, in vitro growth experiments showed that L-fucose
stimulated utilization of D-ribose by the E. coli MG1655 fucAO mutant but not by an E. coli MG1655 fucK
mutant. Since the fucK mutant cannot convert L-fuculose to L-fuculose-1-phosphate, whereas the fucAO
mutant accumulates L-fuculose-1-phosphate, the data suggest that L-fuculose-1-phosphate stimulates growth
on ribose both in the intestine and in vitro. An E. coli Nissle 1917 fucAO mutant, derived from a human
probiotic commensal strain, acted in a manner identical to that of E. coliMG1655 fucAO in vivo and in vitro.
Furthermore, L-fucose at a concentration too low to support growth stimulated the utilization of ribose by the
wild-type E. coli strains in vitro. Collectively, the data suggest that L-fuculose-1-phosphate plays a role in the
regulation of ribose usage as a carbon source by E. coliMG1655 and E. coli Nissle 1917 in the mouse intestine.
We are interested in identifying the nutrients that Esche-
richia coli uses to successfully colonize the mouse large intes-
tine in the face of competition from an extensive microflora.
The large intestine of the mouse consists of the cecum and the
colon, each of which contains the mucosa and the luminal
contents. The two components of the mucosa are the layer of
epithelial cells on the intestinal wall and the mucus layer that
covers them. The relatively thick (up to 800 m) mucus layer
consists of mucin, a 2-MDa gel-forming glycoprotein and a
large number of smaller glycoproteins, proteins, glycolipids,
lipids, and sugars (1, 3, 15, 28, 46, 47, 51, 52). The mucus layer
itself is in a dynamic state, constantly being synthesized and
secreted by specialized goblet cells and degraded to a large
extent by the indigenous intestinal microbes (25, 41). E. coli is
present both in mucus and luminal contents; however, a large
body of experimental evidence shows that growth is rapid in
intestinal mucus both in vitro and in vivo but is either poor or
completely inhibited in luminal contents (33, 38, 43, 52, 53, 55).
It is therefore highly likely that the ability of an E. coli strain to
grow in intestinal mucus plays a critical role in its ability to
colonize the intestine.
The prevalent theory as to how bacteria colonize the mam-
malian gut has been called the nutrient-niche theory. This
theory states that the 500 to 1,000 indigenous species that
make up the microflora (39) can coexist in the large intestine
as long as each member is able to utilize one or a few limiting
nutrients better than all the others and that the rate of growth
of any member of the microflora that successfully colonizes is
at least equal to the washout rate from the intestine (19, 20,
21). It is the presence of a complete microflora that results in
what has been termed colonization resistance, which refers to
the ability of the intestinal microflora to resist colonization by
an invading bacterium (2, 20, 22, 54). Due to colonization
resistance, studies aimed at determining how an invading bac-
terium colonizes the mouse intestine are difficult, if not impos-
sible, with conventional animals. However, intestinal coloniza-
tion can be studied with the streptomycin-treated mouse,
which has been used extensively to study E. coli, Salmonella
enterica serovar Typhimurium, and Klebsiella pneumoniae in-
testinal colonization (14, 34, 42, 43).
Streptomycin treatment alters the microecology of the ce-
cum, decreasing the populations of facultative anaerobes and
some strict anaerobes and creating a niche for organisms such
as E. coli (23). Nevertheless, populations of the genera Bacte-
roides and Eubacterium in cecal contents of streptomycin-
treated mice remain largely unchanged (23). Moreover, the
overall number of strict anaerobes in the cecal contents of
streptomycin-treated and conventional mice is essentially iden-
tical (1  109 to 2  109 CFU/g of contents) (23). Therefore,
while the streptomycin-treated mouse model is not perfect,
invading microorganisms must compete for nutrients with a
large number of strict anaerobes in the intestine, just as they do
in conventional animals. This feature makes the streptomycin-
treated mouse model the one of choice to identify the nutrients
* Corresponding author. Mailing address: Department of Cell and
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E. coli uses to colonize the mouse intestine in the face of
competition from an extensive microflora.
Using the streptomycin-treated mouse model, it recently has
been shown that E. coli MG1655, a human commensal strain
for which the genome has been completely sequenced (5),
utilizes several sugars simultaneously for growth in the mouse
intestine (7). While these results support the nutrient-niche
theory of colonization, the mechanisms governing the simulta-
neous use of sugars are largely unknown. In the present study,
we report that while studying the role of L-fucose as a nutrient
for E. coli MG1655 and E. coli Nissle 1917 in the mouse
intestine, we found that accumulation of L-fuculose-1-phos-
phate, an intermediate in the degradation of L-fucose in E. coli,
stimulates utilization of D-ribose. The present studies therefore
raise the possibility that pool sizes of metabolic intermediates
play a role in the selection of nutrients used by E. coli MG1655
and E. coli Nissle 1917 to achieve maximum colonizing ability.
MATERIALS AND METHODS
Bacterial strains. E. coli MG1655 Strr is a spontaneous streptomycin-resistant
mutant of the sequenced wild-type E. coli MG1655 strain (CGSC 7740) (37). E.
coli MG1655 Strr Nalr is a spontaneous nalidixic acid-resistant mutant of E. coli
MG1655 Strr (37). It is referred to in the text as E. coli MG1655. The following
deletion mutants were constructed from E. coli MG1655 Strr as described below
in the section on mutant construction. E. coli MG1655 Strr fucAO::kan is both
streptomycin resistant and kanamycin resistant and has a 1,542-bp deletion
within the 1,823-bp fucA and fucO genes. It is unable to convert fuculose-1-
phosphate to dihydroxyacetone phosphate and lactaldehyde and lacks both L-
fuculose phosphate aldolase and propanediol oxidoreductase. It is referred to in
the text as E. coli MG1655 fucAO. E. coli MG1655 Strr rbsK::cam has a 759-bp
deletion of the 929-bp rbsK gene (7). It is unable to convert ribose to ribose-5-
phosphate, lacks ribokinase, and is both streptomycin and chloramphenicol re-
sistant. It is referred to in the text as E. coli MG1655 rbsK. E. coli MG1655 Strr
fucAO rbsK::cam has the identical 1,542-bp deletion in the fucA and fucO
genes as described above but is missing the kanamycin cassette. In addition, it has
a 759-bp deletion in the rbsK gene as described above. It is both streptomycin
resistant and chloramphenicol resistant and is referred to in the text as E. coli
MG1655 fucAO rbsK. E. coli MG1655 Strr fucK::kan has a 993-bp deletion
of the 1,448-bp fucK gene. It is unable to convert fuculose to fuculose-1-phos-
phate, lacks L-fuculokinase, and is both streptomycin and kanamycin resistant.
Wild-type E. coli Nissle 1917 was obtained from Dean Hamer of the National
Cancer Institute. E. coli Nissle 1917 Strr is a spontaneous streptomycin-resistant
mutant of the wild-type strain. E. coli Nissle 1917 Strr Nalr is a spontaneous
nalidixic acid-resistant mutant of E. coli Nissle 1917 Strr and is referred to in the
text as E. coli Nissle 1917. The following deletion mutants were constructed from
E. coli Nissle 1917 Strr as described below (see the section on mutant construc-
tion): E. coli Nissle 1917 Strr fucAO::kan, E. coli Nissle 1917 Strr rbsK::kan, E.
coli Nissle 1917 Strr fucAO rbsK::cam, and E. coli Nissle 1917 Strr fucK::cam.
The mutants contain the same deletions as their E. coli MG1655 counterparts
and are referred to in the text as E. coli Nissle 1917 fucAO, E. coli Nissle 1917
rbsK, E. coli Nissle 1917 fucAO rbsK, and E. coli Nissle 1917 fucK, respec-
tively.
Media and growth conditions. Luria broth (LB) was made as described by
Revel (48). Luria agar is LB containing 12 g of Bacto agar (Difco) per liter.
MacConkey agar (Difco) was prepared according to the manufacturer’s instruc-
tions. For testing the ability of E. coli strains to utilize D-ribose or L-fucose,
overnight cultures grown in LB were washed twice in M9 minimal medium (no
carbon source), 10 l of the washed cultures was transferred to 10 ml of M9
minimal medium (35) containing reagent-grade glycerol (0.4%, wt/wt) as the sole
carbon and energy source, and cultures were incubated at 37°C with shaking in
125-ml tissue culture bottles. Growth and the lack of growth were assessed
visually. For testing the ability of L-fucose to induce the utilization of D-ribose in
E. coli MG1655 and in E. coli Nissle 1917 fucAO and fucK mutants, the
mutants were grown twice in M9 minimal medium containing glycerol (0.2%,
wt/wt) as described above and then were washed and resuspended at an A600 of
0.1 in three separate 20-ml volumes of M9 minimal medium containing either
0.05% fucose, 0.15% ribose, or 0.05% fucose and 0.15% ribose. The cultures
were incubated at 37°C with shaking in 125-ml tissue culture bottles. Growth was
monitored spectrophotometrically (A600) using a Pharmacia Biotech Ultrospec
2000 UV/visible spectrophotometer.
Mutant construction. Mutant E. coli strains were created by deletion mu-
tagenesis using either a chloramphenicol cassette or a kanamycin cassette as
described by Datsenko and Wanner (12). Primers used to construct deletion
mutants were designed according to the E. coli MG1655 genome sequence
(5). DNA procedures were as described previously (37). All constructs were verified
by PCR and sequencing. The primers used to construct the fucAO deletions were
the following (uppercase letters, MG1655 DNA; lowercase letters, kanamycin cas-
sette DNA): primer 1, 5-CGCAAATGTGGCGGAATACCGACATCACGGTT
GAGAGCAAACAgtgtaggctggagctgcttcg-3; primer 2, 5-CGTCAGTGTACGTTA
TCAGGATGGGATGCTGATTACGCCTACAGGCAtatgaatatcctccttag-3. The
primers used to construct the rbsK deletions were the following (uppercase letters,
MG1655 DNA; lowercase letters, chloramphenicol or kanamycin cassette DNA):
primer 1, 5-TGGCAGCATTAATGCTGACCACATTCTTAATCTTCAATCTT
TTCCTACTCtgtaggctggagctgcttcg-3; primer 2, 5-GGTACGGAAGGTTGTGCG
CCTTTACGTGTTACGGCAATCGCAGCGGCAGGCAtatgaatatcctccttag-3. The
primers used to construct the fucK deletions were the following (uppercase
letters, MG1655 DNA; lowercase letters, chloramphenicol or kanamycin cassette
DNA): primer 1, 5-CTGTGGCGCGACCAATGTCAGGGCCATCGCGGTT
AATCGGCAGGGgtgtaggctggagctgcttcg-3; primer 2, 5-GTACGACTTAACA
GCGAAGTATCAACCTGGGCGCTGCGAACCATCAtatgaatatcctccttag-3.
Sequencing. DNA sequencing was done at the URI Genomics and Sequencing
Center, University of Rhode Island, Kingston, using the CEQ8000 genetic anal-
ysis system (Beckman Coulter, Fullerton, CA). The dye terminator cycle se-
quencing quick start kit (Beckman Coulter) was used in the sequencing reactions.
The primers used to amplify PCR products for sequencing to determine the
precise location of the deletions for E. coli MG1655 fucK and E. coli Nissle 1917
fucK were 5-TATGCACAACGTTGAAGACACC-3 and 5-CCACAATGT
GTTGCGACTTCCTC-3. The same primers were used for sequencing. For E.
coli MG1655 fucAO and E. coli Nissle 1917 fucAO PCR amplification, the
primers were the following: 5-GCTTACAAACCGATTTGCATATC-3 and 5-
GTGGGTAATTAAACGGCTAATTC-3; for sequencing, the primers were 5-
AACAGTACTGCGATGAGTGGCAG-3 and 5-GCGAAGTGATCTTCCGT
CACAGGT-3. For E. coli MG1655 rbsK PCR amplification, the primers were
5-GGTTGTATGACCTGATGGTGAC-3 and 5-GAGAAACTG TTGAGGT
AGAAACG-3. The same primers were used for sequencing. For E. coli Nissle
1917 rbsK PCR amplification, the primers were 5-CGTTGTATGACCTGAT
GGTGAC-3 and 5-GAGAAACT GTTGAGGTAGAAACG-3. The same
primers were used for sequencing.
Mouse colonization experiments. The method used to compare the large
intestine-colonizing abilities of E. coli strains in mice has been described previ-
ously (52, 53, 55). Briefly, three male CD-1 mice (5 to 8 weeks old) were given
drinking water containing streptomycin sulfate (5 g/liter) for 24 h to eliminate
resident facultative bacteria (36). Following 18 h of starvation for food and water,
the mice were fed 1 ml of 20% (wt/vol) sucrose containing LB-grown E. coli
strains, as described in the Results section. After ingesting the bacterial suspen-
sion, both the food (Harlan Teklad Mouse and Rat Diet, Madison, WI) and
streptomycin-water were returned to the mice, and 1 g of feces was collected
after 5 h, 24 h, and on odd-numbered days at the indicated times. Mice were
housed individually in cages without bedding and were placed in clean cages
daily. Fecal samples (no older than 24 h) were homogenized in 1% Bacto
tryptone, diluted in the same medium, and plated on MacConkey agar plates
with appropriate antibiotics. Plates contained streptomycin sulfate (100 g/ml)
and nalidixic acid (50 g/ml), streptomycin sulfate (100 g/ml) and kanamycin
sulfate (40 g/ml), or streptomycin sulfate (100 g/ml) and chloramphenicol (30
g/ml). Antibiotics were purchased from Sigma-Aldrich (St. Louis, MO). All
plates were incubated for 18 to 24 h at 37°C prior to counting. Each colonization
experiment was performed at least twice, with essentially identical results. Pooled
data from at least two independent experiments are presented in the figures.
RESULTS
Sequencing and growth of mutants in vitro. All mutants
used in this study were sequenced to be sure that the deletions
were in the expected places in the chromosome (see Materials
and Methods). In addition, each mutant was tested for growth
in M9 minimal medium containing 0.4% (wt/wt) glycerol, fu-
cose, or ribose as the sole carbon and energy source. All mu-
tants grew normally with glycerol as the sole carbon and energy
source. Furthermore, all mutants with a fucAO deletion or a
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fucK deletion failed to grow with fucose as the sole carbon
and energy source, and those with a rbsK deletion failed to
grow with ribose as the sole carbon and energy source. More-
over, fucAO rbsK double mutants failed to grow on a mix-
ture of fucose and ribose.
Mouse intestinal colonization of E. coli MG1655 fucAO
and rbsK mutants. Unlike its wild-type parent, E. coli
MG1655 fucAO cannot convert fuculose-1-phosphate to di-
hydroxyacetone phosphate and lactaldehyde (Fig. 1A) and
therefore is unable to use fucose as a carbon and energy
source. Similarly, E. coli MG1655 rbsK cannot phosphorylate
ribose to ribose-5-phosphate and therefore is unable to utilize
ribose as a carbon and energy source (Fig. 1B). When mice
were fed 105 CFU each of wild-type E. coli MG1655 and E. coli
MG1655 fucAO, the wild-type E. coli MG1655 grew to a level
of about 108 CFU/g of feces within 1 day after feeding and then
within a few days stabilized at a level of about 107 CFU/g of
feces, whereas E. coli MG1655 fucAO initially grew to a level
of only about 107 CFU/g of feces and within a few days stabi-
lized at a level of about 105 CFU/g of feces (Fig. 2A). When
mice were fed 105 CFU each of wild-type E. coli MG1655 and
E. coli MG1655 rbsK, both grew at the same rate in the
intestine to about 108 CFU/g of feces, and only thereafter did
the E. coli MG1655 wild type, which stabilized at a level of
about 107 CFU/g of feces, develop a very slight advantage, at
most fourfold, over E. coli MG1655 rbsK (Fig. 2B). There-
fore, E. coli MG1655 appeared to use fucose during the
initiation stage of the colonization process but appeared to
stop using it during maintenance. In contrast, ribose did not
appear to be used to any great extent during either stage of
colonization.
E. coli MG1655 fucAO appears to switch to ribose in the
intestine. Since E. coli MG1655 rbsK was nearly as good a
colonizer as wild-type E. coli MG1655, it was expected that the
colonizing ability of an E. coli MG1655 fucAO rbsK double
mutant would closely mimic the colonizing ability of E. coli
MG1655 fucAO. Surprisingly, when mice were fed 105 CFU
each of the wild-type E. coli MG1655 and E. coli MG1655
fucAO rbsK, the double mutant proved to be a far worse
colonizer than expected, essentially being eliminated by day 15
after feeding (Fig. 2C). These data suggested the possibility
that the E. coli MG1655 fucAO mutant switched to ribose in
the intestine. If true, the E. coli MG1655 fucAO rbsK double
mutant should be a far worse colonizer than the E. coli
MG1655 fucAO mutant, despite differing only in the ability to
utilize ribose for growth. Indeed, the E. coli MG1655 fucAO
rbsK double mutant was rapidly eliminated in competition
with E. coli MG1655 fucAO (Fig. 2D), suggesting that the E.
coli MG1655 fucAO mutant, in contrast to the wild-type E.
coli MG1655, utilizes ribose for growth in the intestine.
When mice are fed high numbers (1010 CFU/mouse) of a
wild-type E. coli strain (resistant to streptomycin) and low
numbers (105 CFU/mouse) of the same wild-type strain (e.g.,
resistant to streptomycin and nalidixic acid), they maintain the
initial ratio of their input values (52), as would be expected of
two strains that use all nutrients equally well. It then would be
expected that if wild-type E. coli MG1655 was fed to mice in
high numbers (1010 CFU/mouse) and the E. coli MG1655
fucAO mutant was fed to the same mice in low numbers (105
CFU/mouse) and the only difference between the two strains
was their ability to utilize fucose for growth, the fucAO mu-
tant would stabilize in numbers 5 orders of magnitude lower
than those for both strains being fed to mice in equal numbers,
i.e., a total of about 7 orders of magnitude. On the other hand,
if the E. coli MG1655 fucAO mutant was using ribose and the
wild-type E. coli MG1655 was not, the E. coli MG1655 fucAO
mutant could conceivably grow from low numbers to higher
numbers in the presence of high numbers of the wild-type
strain and could colonize at the level observed when both
strains were fed to the mice in low numbers, i.e., only 2 orders
of magnitude lower than the level of the wild type (Fig. 1A).
This is precisely what happened, i.e., when mice were fed 1010
CFU of the wild-type E. coli MG1655 and 105 CFU of the E.
coli MG1655 fucAO mutant, the mutant grew from a level of
5 orders of magnitude lower than that of its parent to only 2
orders of magnitude lower within a few days (Fig. 2E).
The switch to ribose appears to require fuculose-1-phos-
phate. Because the E. coli MG1655 fucAO mutant cannot
FIG. 1. Fucose operons and degradation pathway (A) and the ribose operon and degradation pathway (B). Arrows above genes indicate
promoters and the direction of transcription. MFS, major facilitator superfamily; ABC, ATP-binding cassette.
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convert fuculose-1-phosphate to dihydroxyacetone phosphate
and lactaldehyde (8) and because fuculose-1-phosphate is re-
quired for induction of the fucPIKUR operon (4), E. coli
MG1655 fucAO most likely accumulates fuculose-1-phos-
phate in the presence of fucose. Since the E. coli MG1655
fucAO mutant appeared to be using ribose for growth in the
intestine, the question was whether the switch to ribose re-
quires the presence of fuculose-1-phosphate. An E. coli
FIG. 2. Colonization of the mouse intestine by E. coli MG1655 fucAO, E. coli MG1655 rbsK, and E. coli MG1655 fucAO rbsK. Sets of
three mice were fed 105 CFU of E. coli MG1655 (f) and 105 CFU of MG1655 fucAO (E) (A); 105 CFU of E. coli MG1655 (f) and 105 CFU
of E. coli MG1655 rbsK (E) (B); 105 CFU of E. coli MG1655 (f) and 105 CFU of E. coli MG1655 fucAO rbsK (E) (C); 105 CFU of E. coli
MG1655 fucAO (f) and 105 CFU of E. coli MG1655 fucAO rbsK (E) (D); and 1010 CFU of E. coli MG1655 (f) and 105 CFU of E. coli
MG1655 fucAO (E) (E). At the indicated times, fecal samples were homogenized, diluted, and plated as described in Materials and Methods.
Bars representing standard errors of the log10 means of CFU per gram of feces for six mice are presented for each time point except for panels
A and B, for which data from 12 mice are presented. Each colonization curve has the specific strain genotype immediately above or below it. wt,
wild-type E. coli MG1655.
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MG1655 fucK mutant, which is defective in the phosphory-
lation of fuculose to fuculose-1-phosphate (Fig. 1A), was em-
ployed to address this question. When mice were fed 105 CFU
each of wild-type E. coli MG1655 and E. coli MG1655 fucK,
the mutant colonized at most fivefold below the level of its
wild-type parent (Fig. 3A). When the E. coli MG1655 fucK
mutant was fed to mice at 105 CFU/mouse and wild-type E. coli
MG1655 was simultaneously fed at 1010 CFU/mouse, the E.
coli MG1655 fucK mutant was eliminated (Fig. 3B). There-
fore, the E. coli MG1655 fucK mutant does not use ribose,
and neither does it switch to any other nutrient in the intestine
to allow it to grow up in the presence of high numbers of
wild-type E. coli MG1655. Moreover, since the only difference
between the E. coli MG1655 fucK mutant and the E. coli
MG1655 fucAO mutant is the inability of the E. coli MG1655
fucK mutant to accumulate fuculose-1-phosphate, i.e., nei-
ther mutant is able to make dihydroxyacetone phosphate and
lactaldehyde (Fig. 1A), it would appear that the switch of E.
coli MG1655 fucAO to ribose in the intestine requires the
accumulation of fuculose-1-phosphate.
Fucose stimulates the utilization of ribose for growth by E.
coli MG1655 fucAO in vitro but not for growth by E. coli
MG1655 fucK. Since it appeared that fucose stimulates utili-
zation of ribose by E. coli MG1655 fucAO in the intestine,
growth experiments were performed to determine whether fu-
cose could stimulate utilization of ribose by E. coli MG1655
fucAO in vitro. E. coli MG1655 fucAO and E. coli MG1655
fucK were grown in M9 minimal medium in the presence
of 0.05% fucose, 0.15% ribose, and a mixture of 0.05%
fucose and 0.15% ribose. As expected, neither strain grew
with fucose as the sole carbon and energy source (Fig. 4).
However, fucose stimulated more rapid growth of E. coli
MG1655 fucAO on ribose (Fig. 4A) but had no effect on the
rate of growth of E. coli MG1655 fucK on ribose (Fig. 4B).
That the stimulation of ribose utilization required a functional
rbsK gene was shown by the fact that the E. coli MG1655
fucAO rbsK mutant failed to grow on ribose in the presence
or absence of fucose (data not shown). Collectively, these in
vitro data support the idea that it is accumulation of fuculose-
1-phosphate that stimulates growth of E. coli MG1655 fucAO
on ribose in the mouse intestine.
Fucose has no effect on utilization of N-acetylglucosamine,
but it inhibits the utilization of galactose and mannose for
growth by E. coli MG1655 fucAO in vitro. Both E. coli
MG1655 fucK and E. coli MG1655 fucAO are unable to use
fucose for growth, but E. coli MG1655 fucAO switches to
ribose in the intestine, whereas the switch to ribose is not made
by E. coli MG1655 fucK. Why then is E. coli MG1655 fucK
a better colonizer than E. coli MG1655 fucAO when each is
in competition with wild-type E. coli MG1655 (compare Fig.
2A to 3A)? One possibility was that while accumulation of
fuculose-1-phosphate in E. coli MG1655 fucAO stimulates
utilization of ribose, it might simultaneously inhibit utilization
of other sugars. Growth experiments analogous to those de-
scribed for the effect of fucose on ribose utilization also were
performed to determine the effect of fucose on utilization of
N-acetylglucosamine, galactose, and mannose for growth by E.
coli MG1655 fucAO and E. coli MG1655 fucK in vitro.
Indeed, although 0.05% fucose had no effect on the utilization
of 0.15% N-acetylglucosamine by E. coli MG1655 fucAO in
vitro (Fig. 5A), it greatly reduced the utilization of both galac-
tose and mannose (Fig. 5B and C). In contrast, utilization of
N-acetylglucosamine, galactose, and mannose was unaltered by
fucose in the E. coli MG1655 fucK mutant (data not shown).
It therefore seems likely that E. coli MG1655 fucAO is a
worse colonizer than E. coli MG1655 fucK, despite using
ribose more efficiently, because accumulation of fuculose-1-
phosphate inhibits its ability to compete for other sugars that
are normally used for growth in the intestine.
Fucose stimulates ribose utilization for growth by wild-type
E. coliMG1655 in vitro. In vitro growth experiments also were
performed to determine whether fucose could stimulate utili-
zation of ribose by wild-type E. coli MG1655 in vitro. In this
case, it was necessary to use a concentration of fucose that
FIG. 3. Colonization of the mouse intestine by E. coli MG1655 fucK. Sets of three mice were fed 105 CFU of E. coli MG1655 (f) and 105
CFU of MG1655 fucK (E) (A) or 1010 CFU of E. coli MG1655 (f) and 105 CFU of E. coli MG1655 fucK (E) (B). At the indicated times, fecal
samples were homogenized, diluted, and plated as described in Materials and Methods. Bars representing standard errors of the log10 means of
CFU per gram of feces for 12 mice are presented for each time point in panel A and for 6 mice in panel B. Each colonization curve has the specific
strain genotype immediately above or below it. wt, wild-type E. coli MG1655.
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would not allow E. coli MG1655 to grow but might still stim-
ulate ribose utilization. Therefore, E. coli MG1655 was grown
in the presence of 0.005% fucose, 0.15% ribose, or a mixture of
0.005% fucose and 0.15% ribose. Wild-type E. coli MG1655
did not grow in the presence of 0.005% fucose, but 0.005%
fucose did stimulate the utilization of ribose by wild-type E.
coli MG1655 (Fig. 6). It therefore appears that stimulation of
ribose utilization by fucose also can occur in wild-type E. coli
MG1655 at fucose concentrations too low to allow growth,
suggesting the possibility that under the right conditions, fu-
cose could signal wild-type E. coli MG1655 to utilize ribose in
the intestine.
E. coli Nissle 1917 fucAO also switches to ribose in the
intestine. Experiments were conducted to determine whether
the switch to ribose in the intestine by E. coli MG1655 fucAO
was an isolated case or whether other E. coli strains carry out
the switch. E. coli Nissle 1917 is a commensal strain that has
been used successfully as a probiotic agent to treat gastroin-
testinal infections in humans since the early 1920s (50). Like E.
coli MG1655 fucAO, an E. coli Nissle 1917 fucAO mutant
colonized at a level about 2 orders of magnitude less than that
of its wild-type parent when 105 CFU of each strain was fed to
mice (Table 1). Also like E. coli MG1655 rbsK, an E. coli
Nissle 1917 rbsK mutant colonized at a level of only about
fourfold lower than that of its wild-type parent when 105 CFU
of each strain was fed to mice (Table 1). In addition, an E. coli
Nissle 1917 fucAO rbsK mutant colonized at a level of about
5 orders of magnitude lower than that of its wild-type parent
when 105 CFU of each strain was fed to mice, i.e., greater than
2 orders of magnitude lower than expected (Table 1). Further-
more, when mice were fed 1010 CFU of wild-type E. coli Nissle
1917 and 105 CFU of the E. coli Nissle 1917 fucAO mutant,
the mutant grew from a level of 5 orders of magnitude lower
than that of its parent to between 1.5 and 2 orders of magni-
tude lower within a few days (Table 1). Therefore, like E. coli
MG1655 fucAO, the E. coli Nissle 1917 fucAO mutant ap-
pears to use ribose for growth in the intestine.
Mice also were fed 105 CFU each of wild-type E. coli Nissle
1917 and an E. coli Nissle 1917 fucK mutant. The E. coli
Nissle 1917 fucK mutant colonized at a level of between 1 and
2 orders of magnitude lower than that of the wild-type strain
(Table 1). In addition, when mice were fed 1010 CFU of wild-
type E. coli Nissle 1917 and 105 CFU of E. coli Nissle 1917
fucK, the E. coli Nissle 1917 fucK mutant was essentially
eliminated (Table 1). Collectively, these data suggest that the
E. coli Nissle 1917 fucK mutant does not switch to ribose in
the intestine and that, like the E. coli MG1655 fucAO mutant,
the E. coli Nissle 1917 fucAO mutant switches to ribose for
growth in the intestine, mediated by the accumulation of fu-
culose-1-phosphate.
Fucose stimulates the utilization of ribose by wild-type E.
coli Nissle 1917 and by E. coli Nissle 1917 fucAO for growth
in vitro. Growth experiments were performed to determine
whether fucose could stimulate utilization of ribose in the E.
coli Nissle 1917 fucAO mutant in vitro. The E. coli Nissle
1917 fucAO mutant and the E. coli Nissle 1917 fucK mutant
were grown in vitro in the presence of 0.05% fucose, 0.15%
ribose, and 0.05% fucose plus 0.15% ribose. As expected, nei-
ther strain grew on fucose as the sole carbon and energy
source. However, fucose was able to induce more rapid growth
of E. coli Nissle 1917 fucAO on ribose (Fig. 7A). Fucose did
not induce more rapid growth of the E. coli Nissle 1917 fucK
mutant on ribose (Fig. 7B). Moreover, fucose had no effect on
N-acetylglucosamine utilization but inhibited both mannose
and galactose utilization in the E. coli Nissle 1917 fucAO
mutant (data not shown). Fucose had no effect on N-acetyl-
glucosamine, galactose, or mannose utilization by E. coli Nissle
1917 fucK (data not shown). It therefore appears that as in
the case of E. coli MG1655, accumulation of fuculose-1-phos-
phate induces more rapid growth of the commensal E. coli
Nissle 1917 fucAO mutant on ribose in vitro, has no effect on
N-acetylglucosamine utilization, and inhibits both galactose
and mannose utilization. Finally, wild-type E. coli Nissle 1917
was grown in the presence of 0.005% fucose, 0.15% ribose, or
FIG. 4. Growth of E. coli MG1655 fucAO (A) and E. coli MG1655 fucK (B) in M9 minimal medium in the presence of 0.05% (wt/wt) fucose
(f), 0.15% (wt/wt) ribose (}), or a mixture of 0.05% (wt/wt) fucose and 0.15% (wt/wt) ribose (E). E. coli MG1655 fucAO and E. coli MG1655
fucK were grown in M9 minimal medium containing glycerol (0.2%, wt/wt), washed, and resuspended in M9 minimal medium containing the
appropriate sugars (see Materials and Methods). Incubation was at 37°C with aeration. A600 readings at the indicated times are presented. Growth
experiments were performed at least three times. The results of typical experiments are shown.
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a mixture of 0.005% fucose and 0.15% ribose. Again, like E.
coli MG1655, the wild-type E. coli Nissle 1917 did not grow in
the presence of 0.005% fucose, but 0.005% fucose did stimu-
late its use of ribose (Fig. 7C).
DISCUSSION
It is becoming increasingly clear that in the face of compe-
tition from a complex microflora, E. coli simultaneously uses
several, presumably limiting, sugars for growth in the mouse
intestine, including D-gluconate, N-acetyl-D-glucosamine,
D-glucuronate, and sialic acid (7, 10, 30, 31). The simultaneous
use of several sugars for growth is not unprecedented. In fact,
E. coli has been shown to utilize D-glucose, D-galactose, D-
maltose, D-ribose, L-arabinose, and D-fructose simultaneously
in a chemostat under carbon-limiting conditions (32). It also
appears that E. coli is capable of preparing itself for the ap-
pearance of alternative carbon sources when growing under
glucose-limiting conditions or when utilizing acetate as the sole
carbon source (18, 44). Thus, DNA microarray analysis has
shown that when E. coli was grown in a chemostat under
glucose-limiting conditions, genes associated with the maltose
and galactose operons were up-regulated relative to batch cul-
tures grown under conditions in which glucose was not limited
(18). Similarly, with acetate as the sole carbon source, genes
encoding transporters for galactose, ribose, and N-acetylglu-
cosamine were up-regulated relative to growth with glucose
as the sole carbon source (44). Moreover, using Biolog AN
MicroPlate respiration analysis, it has recently been shown that
when E. coli MG1655 was grown in a chemostat under glucose-
limiting conditions, despite the absence of inducers a wide
variety of catabolic functions were derepressed (26).
There are two divergently transcribed operons for fucose
utilization in E. coli (Fig. 1A), the fucPIKUR operon, which
takes fucose to fuculose-1-phosphate, and the fucAO operon,
which takes fuculose-1-phosphate to dihydroxyacetone phos-
phate and lactaldehyde (8). Fuculose-1-phosphate is the effec-
tor of induction of both fucose operons through the FucR
activator protein (4, 8, 9). In the present study, evidence is
FIG. 5. Growth of E. coli MG1655 fucAO in M9 minimal medium in the presence of 0.05% (wt/wt) fucose (f), 0.15% (wt/wt) N-
acetylglucosamine (}), or a mixture of 0.05% (wt/wt) fucose and 0.15% (wt/wt) N-acetylglucosamine (E) (A); 0.05% (wt/wt) fucose (f), 0.15%
(wt/wt) mannose (}), or a mixture of 0.05% (wt/wt) fucose and 0.15% (wt/wt) mannose (E) (B); and 0.05% (wt/wt) fucose (f), 0.15% (wt/wt)
galactose (}), or a mixture of 0.05% (wt/wt) fucose and 0.15% (wt/wt) galactose (E) (C). E. coli MG1655 fucAO was grown in M9 minimal
medium containing glycerol (0.2%, wt/wt), washed, and resuspended in M9 minimal medium containing the appropriate sugars (see Materials and
Methods). Incubation was at 37°C with aeration. A600 readings at the indicated times are presented. Growth experiments were performed at least
three times. The results of typical experiments are shown.
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presented suggesting that accumulation of fuculose-1-phos-
phate through induction of the fucPIKUR operon in two com-
mensal strains, E. coli MG1655 fucAO and E. coli Nissle 1917
fucAO, stimulates growth on ribose both in the intestine and
in vitro. However, in a fucAO mutant, in addition to accumu-
lation of fuculose-1-phophate, it would be expected that the
fuculose transporter (FucP) encoded by fucP, the FucR acti-
vator protein encoded by fucR, and the L-fucose mutarotase
encoded by fucU also would accumulate. It recently has been
reported (49) that the L-fucose mutarotase can convert -D-
pyranoribose, the form transported into the cell, to -D-ribo-
furanose (49). -D-Ribofuranose is required for ribose catab-
olism (40). It also has recently been reported that D-fructose
possibly can enter an E. coli fucA mutant via FucP (29). If
ribose were to enter fucAO cells via FucP, it then could
induce the ribose operon. In this case and in the case of the
mutarotase, the fuculose-1-phosphate would be necessary
only for inducing the fucPIKUR operon. Whether the L-fucose
permease and/or the L-fucose mutarotase is involved in stim-
ulation of ribose utilization is presently under investigation.
At the present time, it is not clear how or if fuculose-1-
phosphate is involved either by itself or as an effector in com-
bination with a regulatory protein in inducing the rbsDABCKR
operon. It is possible that accumulated fuculose-1-phosphate
acts as an effector of FucR to directly activate or release re-
pression of transcription of the rbsDABCKR operon. In Bac-
teroides thetaiotaomicron, L-fucose has been implicated through
its FucR protein, which is unrelated to the E. coli FucR pro-
tein, to both induce the fucose operon and, along with FucR,
to corepress an as-yet unidentified locus named cps (control of
signal production) that may be responsible for inducing the
mammalian host to make hydrolysable fucosylated glycans
(24). Moreover, it has been shown that transcription of the
ribose operon is repressed by XylR, the xylose regulator, in the
presence of xylose (27). It is therefore not farfetched to suggest
the possibility that in commensal E. coli strains fuculose-1-
phosphate and FucR also regulate more than one operon. It
also is possible that fuculose-1-phosphate interacts with the
RbsR repressor protein or an as-yet unidentified protein to
relieve repression of the ribose operon. Finally, it is possible
that fuculose-1-phosphate is involved in opening a gate for
ribose entry into the cells via a preexisting RbsABC trans-
porter or in allosterically activating more of the ribose gene
products.
It appears that accumulation of fuculose-1-phosphate inhib-
its growth of both E. coli MG1655 fucAO and E. coli Nissle
1917 fucAO on mannose and galactose. This finding is not
unexpected; i.e., it is well known that intracellular accumula-
tion of sugar phosphates is inhibitory to E. coli growth, al-
though the reasons remain unclear (6, 11, 13, 16, 17, 56).
However, in view of the fact that sugar phosphates normally
inhibit growth, it is unexpected that accumulation of fuculose-
1-phosphate would stimulate growth of E. coli MG1655 fucAO
and E. coli Nissle 1917 fucAO on ribose. Nevertheless, stim-
ulation of ribose utilization by fuculose-1-phosphate appears
to be a normal physiological process; i.e., fucose at a concen-
tration too low to allow growth (0.005%) stimulated ribose
utilization in both wild-type E. coli MG1655 and wild-type E.
coli Nissle 1917 in vitro (Fig. 6 and 7C). In this context, al-
though both fucose operons are activated by FucR in the
presence of fuculose-1-phosphate (4, 9), it is possible that at
low fucose concentrations the fucPIKUR operon is more highly
expressed than the fucAO operon in wild-type E. coli MG1655,
which could result in the accumulation of fuculose-1-phos-
phate. In fact, the two fucose operons can be expressed differ-
entially (45, 57). The finding that low levels of fucose signal the
wild-type strains to grow more rapidly on ribose raises the
possibility that it also occurs in the intestine, perhaps in a
minor niche. Such wild-type subpopulations presumably would
be at the level of the population size of the fucAO mutants in
the presence of the wild-type strains, i.e., 100-fold below the
FIG. 6. Growth of wild-type E. coli MG1655 in M9 minimal me-
dium in the presence of 0.005% (wt/wt) fucose (f), 0.15% (wt/wt)
ribose (}), or a mixture of 0.005% (wt/wt) fucose and 0.15% (wt/wt)
ribose (E). Wild-type E. coli MG1655 was grown in M9 minimal
medium containing glycerol (0.2%, wt/wt), washed, and resuspended in
M9 minimal medium containing the appropriate sugars (see Materials
and Methods). Incubation was at 37°C with aeration. A600 readings at
the indicated times are presented. Growth experiments were per-
formed at least three times. The results of typical experiments are
shown.
TABLE 1. Mouse intestinal colonization of E. coli Nissle 1917
mutants relative to that of wild-type E. coli Nissle 1917
Sugar Defect inmutant Input
a
Difference between log10
CFU of the wild type and
log10 CFU mutant on day:
3 9
Fucoseb fucAO 0.13  0.15 2.6  0.5 2.3  0.2
Riboseb rbsK 0.18  0.15 0.03  0.08 0.45  0.23
Fucose, riboseb fucAO rbsK 0.27  0.33 2.6  0.4 4.7  0.4
Fucoseb fucK 0.22  0.18 0.60  0.15 1.3  0.1
Fucosec fucAO 4.7  0.6 1.3  0.3 1.7  0.2
Fucosec fucK 4.5  0.5 5.1  0.4 5.5  0.3
a Input values represent the mean of the log10 CFU of the E. coli Nissle 1917
mutant subtracted from the log10 CFU of the wild-type E. coli Nissle 1917 ( the
log10 standard errors of the means) fed to six mice.
b Mice were fed 105 CFU each of an E. coli Nissle 1917 mutant and its
wild-type parent. Mice were transferred to fresh cages every day, and feces no
older than 24 h were assayed every other day for 15 days. At each time point, for
each mouse the log10 CFU/gram of feces for the mutant was subtracted from the
log10 CFU/gram of feces for the wild type. The log10 mean of the difference the
log10 standard error of the mean of day 3 and day 9 fecal data from at least 6 mice
are shown.
c The same procedure as that described in footnote b was followed, except that
mice were fed 105 CFU of an E. coli Nissle 1917 mutant and 1010 CFU of its
wild-type parent.
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wild-type population (Fig. 2E), and would go unnoticed in
routine colonization experiments. Experiments designed to
test this possibility are currently in progress.
The finding that E. coli MG1655 fucAO and E. coli Nissle
1917 fucAO mutants switch to ribose in the intestine because
they accumulate fuculose-1-phosphate not only supports the
nutrient-niche theory but also has far-reaching implications
with respect to the stability of the commensal flora in the
intestine. E. coli and presumably other members of the intes-
tinal microflora use several limiting nutrients simultaneously
for growth (7, 10, 30, 31, 37), but how any member of the
microflora chooses the specific nutrients to use at any one time
among those available to it is largely unknown. The data pre-
sented here suggest that the intracellular pool size of a meta-
bolic intermediate involved in the metabolism of one nutrient
plays a role in this process by signaling E. coli to rapidly switch
to a second unrelated nutrient for growth. Thus, it is possible
that a variety of metabolic intermediates comprise a tier of
regulation designed for E. coli and perhaps other members of
the microflora to more efficiently utilize the available limiting
multiple nutrients to maintain growth rates sufficient to avoid
washout from the intestine.
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